Structural characteristics of compounds that modulate P-glycoprotein-associated multidrug resistance

Schimke, 1978, Amplification of dihydrofolate reductase genes in methotrexate-resistant cultured mouse cells, 42, 649 Glisson, 1986, Cross-resistance to intercalating agents in an epipodophyllotoxin-resistant Chinese hamster ovary cell line: Evidence for a common intracellular target, Cancer Res., 46, 1939 Buller, 1987, Glutathione-S-transferases in nitrogen mustard-resistant and -sensitive cell lines, Mol. Pharmacol., 31, 575 Pastan, 1987, Multiple-drug resistance in human cancer, New Engl. J. Med., 80, 1388 Moscow, 1988, Multidrug resistance, J. Natl. Cancer Inst., 80, 14, 10.1093/jnci/80.1.14 Juliano, 1976, A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants, Biochim. Biophys. Acta, 455, 152, 10.1016/0005-2736(76)90160-7 Cornwell, 1987, ATP-binding properties of P-glycoprotein from multidrug-resistant KB cells, FASEB J., 1, 51, 10.1096/fasebj.1.1.2886389 Kartner, 1983, Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines, Science, 221, 1285, 10.1126/science.6137059 Safa, 1986, Vinblastine photoaffinity labelling of a high molecular weight surface membrane glycoprotein specific for multidrug-resistant cells, J. Biol. Chem., 261, 6137, 10.1016/S0021-9258(19)84537-4 Fojo, 1985, Reduced drug accumulation in multiple drug-resistant human KB carcinoma cell lines, Cancer Res., 45, 3002 Cornwell, 1987, Certain calcium channel blockers bind specifically to multidrug resistant human KB carcinoma membrane vesicles and inhibit drug binding to P-glycoprotein, J. Biol. Chem., 262, 2166, 10.1016/S0021-9258(18)61633-3 Tsuruo, 1981, Overcoming of vincristine and vinblastine by verapamil, Cancer Res., 41, 1967 Ford, 1989, Structural features determining activity of phenothiazines and related drugs for inhibition of cell growth and reversal of multidrug resistance, Mol. Pharmacol., 35, 105 Zamora, 1986, Chloroquine enhancement of anticancer drug cytotoxicity in multiple drug resistant human leukemic cells, Biochem. Pharmacol., 35, 4303, 10.1016/0006-2952(86)90710-0 Beck, 1988, Effects of indole alkaloids on multidrug resistance and labeling of P-glycoprotein by a photoaffinity analog of vinblastine, Biochem. Biophys. Res. Commun., 153, 959, 10.1016/S0006-291X(88)81321-4 Akiyama, 1988, Most drugs that reverse multidrug resistance also inhibit photolabeling of P-glycoprotein by a vinblastine analog, Mol. Pharmacol., 33, 144 Beck, 1979, Altered surface membrane glycoproteins in Vinca alkaloid-resistant human leukemic lymphoblasts, Cancer Res., 39, 2070 Beck, 1986, Reversal of Vinca alkaloid resistance but not multiple drug resistance in human leukemic cells by verapamil, Cancer Res., 46, 778 Beck, 1987, Pharmacologic, molecular, and cytogenetic analysis of “atypical” multidrug-resistant human leukemic cells, Cancer Res., 47, 5455 W. C. STILL, MacroModel was obtained from Prof. W. C. Still, Columbia University, New York, NY. Allinger, 1985, Conformational analysis. 130. MM2. A hydrocarbon force field utilizing V1 and V2 torsional terms, J. Am. Chem. Soc., 99, 8127, 10.1021/ja00467a001 Zamora, 1988, Physical-chemical properties shared by compounds that modulate multidrug resistance in human leukemic cells, Mol. Pharmacol., 33, 454 Leo, 1985, Parameter and structure-activity data bases: Management for maximum utility, Environ. Health Persp., 61, 275, 10.1289/ehp.8561275 Owellen, 1977, Correlation of biologic data with physico-chemical properties among the Vinca alkaloids and their cogeners, Biochem. Pharmacol., 26, 1213, 10.1016/0006-2952(77)90108-3 Pearce, 1989, Essential features of the P-glycoprotein pharmacophore as defined by a series of reserpine analogs that modulate multidrug resistance, 86, 5128